According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 25.893 million shares of the company, accounting for 6.39% of the company's total share capital. On November 4 and 5, 2026, Taichang Group dismissed a total of 3 million shares pledged, accounting for 11.59% of its total shareholding and 0.74% of the company's total share capital. After the completion of this dissolution, Taichang Group pledged a total of 16.41 million shares of the company, accounting for 63.38% of its total shareholding and 4.05% of the company's total share capital.

According to Olin Biotech's announcement, Taichang Group, a shareholder holding more than 5% of the company's shares, holds 25.893 million shares of the company, accounting for 6.39% of the company's total share capital. On November 4 and 5, 2026, Taichang Group dismissed a total of 3 million shares pledged, accounting for 11.59% of its total shareholding and 0.74% of the company's total share capital. After the completion of this dissolution, Taichang Group pledged a total of 16.41 million shares of the company, accounting for 63.38% of its total shareholding and 4.05% of the company's total share capital.